Company Filing History:
Years Active: 2021
Title: **Inventor Spotlight: Soon-min Lim**
Introduction
Soon-min Lim is a distinguished inventor based in Sejong, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in treating inflammatory diseases. With one patent to his name, Lim's work showcases innovation aimed at addressing complex health issues that affect many individuals worldwide.
Latest Patents
Lim's groundbreaking patent focuses on a pharmaceutical composition for preventing and treating inflammatory bowel disease (IBD). This composition comprises a mixed extract of at least two ingredients: Decne, Retzius, and Rosc, serving as active constituents. The patent describes a method that demonstrates an inhibitory effect on monocyte adhesion in intestinal epithelial cells, inhibition of the production of inflammatory cytokines, and an ability to ameliorate colitis in animal models induced by dextran sodium sulfate (DSS). Additionally, it shows promise in treating Crohn's disease in animal models challenged with 2,4,6-trinitrobenzenesulfonic acid (TNBS).
Career Highlights
Lim is currently affiliated with Genuone Sciences Inc., where he applies his expertise to advance therapeutic solutions. His innovative spirit and dedication to research have positioned him as a valuable asset to the company and the broader scientific community.
Collaborations
In his quest for innovation, Lim collaborates with notable colleagues in the field, including Yong-baik Cho and Seul-ki Kim. Together, they participate in fruitful discussions and research projects that enhance their collective understanding and innovations in pharmaceutical developments.
Conclusion
Soon-min Lim's contributions to the treatment of inflammatory bowel disease mark him as an influential inventor. His patent not only highlights his innovative approach but also reflects the promise of scientific advancement in addressing critical health challenges. As he continues his journey in the pharmaceutical realm, the implications of his work may lead to significant improvements in the quality of life for individuals affected by IBD.